NCT05374200

Brief Summary

The investigators have designed a guided, online, multicomponent, mind-body intervention for participants with primary biliary cholangitis. The ability of the online intervention to impact the primary and secondary outcome measures will be assessed as compared to control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
87

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 3, 2021

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 1, 2022

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 9, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 9, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 16, 2022

Completed
Last Updated

August 3, 2022

Status Verified

July 1, 2022

Enrollment Period

6 months

First QC Date

April 1, 2022

Last Update Submit

August 2, 2022

Conditions

Keywords

Mind Body TherapyYogaMeditationBehavior ChangeFatigueQuality of LifeStressDepressionAnxiety

Outcome Measures

Primary Outcomes (1)

  • HADS Anxiety and Depression Scale

    Depression and anxiety will be measured on the Hospital Anxiety and Depression Scale. The minimum score is 0, the maximum score is 21, and higher scores indicate a worse outcome.

    Baseline to 12 weeks

Secondary Outcomes (6)

  • PBC-40

    Baseline to 12 weeks

  • Perceived Stress Scale

    12 Weeks

  • Modified Fatigue Impact Scale

    12 Weeks

  • Connor Davidson Resilience Scale 10

    12 Weeks

  • Lower Extremity Function Scale

    12 Weeks

  • +1 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Participants will receive the standard of care for PBC and access to the online intervention. During the intervention period, participants will also receive weekly brief (\~10-minute) motivational interview style telephone check-ins.

Other: Mind-body intervention with 1-1 support from study personnel

Wait list control group

NO INTERVENTION

During the 12-week wait list period, participants will receive the standard of care for PBC in addition to weekly emails with motivational messages.

Interventions

The multicomponent intervention will consist of the following core components: (1) A choice between three different types of low-intensity, mindful movement videos - chair fitness, standing fitness, or standing tai chi (15-30 minutes/session); (2) Breathwork and theme-of-the-week based mindfulness meditations (5-10 minutes/session); (3) A once weekly positive psychology/behavior change activity presented as a point-and-click interactive storybook within the online site; (4) A once weekly disease management tip from a PBC physician. Weekly brief (\~10-minute) motivational interview style telephone check-ins taking place during the intervention period will be conducted by a member of the study team. During these check-ins, progress will be reviewed, motivation provided, and questions answered.

Also known as: Mind-body intervention
Intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (≥ 18 years)
  • Identified diagnosis of PBC
  • Ability to communicate (read, write, speak) in English
  • Access to an internet connected device at home.

You may not qualify if:

  • Inability to provide informed consent
  • Unsafe to participate in a low-intensity online activity program (e.g. uncontrolled angina or arrhythmia, myocardial infarction or stroke within the last 3 month, other major medical comorbidity of concern)
  • Severe psychiatric disorders (HADS score \>10)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta

Edmonton, Alberta, T6G2C8, Canada

Location

MeSH Terms

Conditions

Liver Cirrhosis, BiliaryFatigueDepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Cholestasis, IntrahepaticCholestasisBile Duct DiseasesBiliary Tract DiseasesDigestive System DiseasesLiver DiseasesLiver CirrhosisFibrosisPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsBehavioral SymptomsBehaviorMental Disorders

Study Officials

  • Puneeta Tandon

    University of Alberta

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Sealed envelopes
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2022

First Posted

May 16, 2022

Study Start

October 3, 2021

Primary Completion

April 9, 2022

Study Completion

April 9, 2022

Last Updated

August 3, 2022

Record last verified: 2022-07

Locations